Justice Department publishes notice on Feb. 21

Justice Department publishes notice on Feb. 21

The US Justice Department published a one page notice on Feb. 21, according to the U.S. Government Publishing Office.

The notice is focused on Importer of Controlled Substances; Notice of Application; Meda Pharmaceuticals, Inc..

The Department is one of the oldest in the US, focused primarily on law enforcement and the federal prison system. Downsizing the Federal Government, a project aimed at lowering taxes and boosting federal efficiency, detailed wasteful expenses such as $16 muffins at conferences and board meetings.

Notices are required documents detailing rules and regulations being proposed by each federal department. This allows the public to see what issues legislators and federal departments are focusing on.

Any person or organization can comment on the proposed rules. Departments and agencies must then address “significant issues raised in comments and discuss any changes made,” the Federal Register says.

Notices published by the Justice Department on Feb. 21

Title
Paroling, Recommitting, and Supervising Federal Prisoners: Prisoners Serving Sentences Under the United States and District of Columbia Codes
Manufacturer of Controlled Substances; Notice of Application; GE Healthcare
Manufacturer of Controlled Substances; Notice of Registration; Cody Laboratories, Inc.
Manufacturer of Controlled Substances; Notice of Registration; INB Hauser Pharmaceutical Services, Inc.
Manufacturer of Controlled Substances; Notice of Registration; Cedarburg Pharmaceuticals, Inc.
Manufacturer of Controlled Substances; Notice of Application; Sigma Aldrich Research Biochemicals, Inc.
Manufacturer of Controlled Substances; Notice of Application; Pharmagra Labs, Inc.
Importer of Controlled Substances; Notice of Application; Caraco Pharmaceutical Laboratories, LTD.
Manufacturer of Controlled Substances; Notice of Application; Mallinckrodt, LLC
Manufacturer of Controlled Substances, Notice of Application; Alltech Associates, Inc.
John V. Scalera; Decision and Order
Importer of Controlled Substances; Notice of Application; Mallinckrodt, LLC.
Brian Earl Cressman, M.D.; Decision and Order
Importer of Controlled Substances; Notice of Application; Meda Pharmaceuticals, Inc.

More News